{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:40:13Z","timestamp":1790354413928,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea Grant funded by the Korean Government MSIT","award":["2020-M3E5D9080787"],"award-info":[{"award-number":["2020-M3E5D9080787"]}]},{"name":"National Research Foundation of Korea Grant funded by the Korean Government MSIT","award":["2021M3E5D1A01015175"],"award-info":[{"award-number":["2021M3E5D1A01015175"]}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["2019-ER7103-02#"],"award-info":[{"award-number":["2019-ER7103-02#"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In a nationwide prospective cohort of Korean infants with very low birthweights (VLBW, birth weight\u2009&lt;\u20091500\u00a0g) from 70 neonatal intensive care units of the Korean Neonatal Network, we investigated neurodevelopmental outcomes in preterm infants with retinopathy of prematurity (ROP) from 2132 infants with VLBW who had undergone developmental assessments at 18\u201324\u00a0months of corrected age. Motor, cognitive, or language delay was determined using developmental scores that were less than 1 standard deviation from the average. Comparative analyses and multivariate regression analyses were performed to validate the association between ROP or its treatment and developmental delay. Motor (52.8% vs. 36.3%), cognitive (46.8% vs. 31.6%), and language delays (42.5% vs. 28.4%) were noted more frequently in infants with ROP than in those without ROP; this was statistically significant (all P\u2009&lt;\u20090.001). Multivariate analyses showed that motor and cognitive delays were significantly associated with ROP. There were no remarkable differences between the neurodevelopmental outcomes and the treatment modalities (laser photocoagulation, anti-vascular endothelial growth factor injection, or both) for ROP, and both stratification and multivariate regression analyses confirmed no significant association between anti-vascular endothelial growth factor therapy and neurodevelopmental delay. As ROP is significantly associated with poor neurodevelopmental outcomes independent of extreme prematurity, neurodevelopmental functions should be given attention in infants with ROP.<\/jats:p>","DOI":"10.1038\/s41598-022-09053-8","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:03:37Z","timestamp":1648058617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neurodevelopmental outcomes in very low birthweight infants with retinopathy of prematurity in a nationwide cohort study"],"prefix":"10.1038","volume":"12","author":[{"given":"Ja-Hye","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Joon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"9053_CR1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1056\/NEJMra1208129","volume":"367","author":"ME Hartnett","year":"2012","unstructured":"Hartnett, M. E. & Penn, J. S. Mechanisms and management of retinopathy of prematurity. N. Engl. J. Med. 367, 2515\u20132526 (2012).","journal-title":"N. Engl. J. Med."},{"key":"9053_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstrom","year":"2013","unstructured":"Hellstrom, A., Smith, L. E. & Dammann, O. Retinopathy of prematurity. Lancet 382, 1445\u20131457 (2013).","journal-title":"Lancet"},{"key":"9053_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1542\/peds.106.5.998","volume":"106","author":"ME Msall","year":"2000","unstructured":"Msall, M. E. et al. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 106, 998\u20131005 (2000).","journal-title":"Pediatrics"},{"key":"9053_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJMoa053792","volume":"355","author":"LJ Woodward","year":"2006","unstructured":"Woodward, L. J., Anderson, P. J., Austin, N. C., Howard, K. & Inder, T. E. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N. Engl. J. Med. 355, 685\u2013694 (2006).","journal-title":"N. Engl. J. Med."},{"key":"9053_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jama.2013.282153","volume":"311","author":"B Schmidt","year":"2014","unstructured":"Schmidt, B., Davis, P. G., Asztalos, E. V., Solimano, A. & Roberts, R. S. Association between severe retinopathy of prematurity and nonvisual disabilities at age 5 years. JAMA 311, 523\u2013525 (2014).","journal-title":"JAMA"},{"key":"9053_CR6","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","volume":"126","author":"YY Fan","year":"2019","unstructured":"Fan, Y. Y. et al. Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: A prospective case-control study. Ophthalmology 126, 1567\u20131577 (2019).","journal-title":"Ophthalmology"},{"key":"9053_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.62.2.2","volume":"62","author":"SJ Ahn","year":"2021","unstructured":"Ahn, S. J. et al. Brain white matter maturation and early developmental outcomes in preterm infants with retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 62, 2 (2021).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"9053_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1542\/peds.2004-0204","volume":"114","author":"MC Walsh","year":"2004","unstructured":"Walsh, M. C. et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114, 1305\u20131311 (2004).","journal-title":"Pediatrics"},{"key":"9053_CR9","doi-asserted-by":"publisher","first-page":"e20183537","DOI":"10.1542\/peds.2018-3537","volume":"144","author":"G Natarajan","year":"2019","unstructured":"Natarajan, G. et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 144, e20183537 (2019).","journal-title":"Pediatrics"},{"key":"9053_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1542\/peds.2012-2996","volume":"131","author":"WM Fierson","year":"2013","unstructured":"Fierson, W. M. et al. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 131, 189\u2013195 (2013).","journal-title":"Pediatrics"},{"key":"9053_CR11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of P","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of P. The international classification of retinopathy of prematurity revisited. Arch. Ophthalmol. 123, 991\u2013999 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"9053_CR12","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/archopht.1987.01060070042025","volume":"105","author":"T Aaberg","year":"1987","unstructured":"Aaberg, T. et al. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch. Ophthalmol. 105, 906\u2013912 (1987).","journal-title":"Arch. Ophthalmol."},{"key":"9053_CR13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","volume":"102","author":"An International Classification of Retinopathy of Prematurity","year":"1984","unstructured":"An International Classification of Retinopathy of Prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch. Ophthalmol. 102, 1130\u20131134 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"9053_CR14","doi-asserted-by":"crossref","unstructured":"An international classification of retinopathy of prematurity. Pediatrics. 74, 127\u2013133 (1984).","DOI":"10.1542\/peds.74.1.127"},{"key":"9053_CR15","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1016\/j.ridd.2013.07.027","volume":"34","author":"L Visser","year":"2013","unstructured":"Visser, L., Ruiter, S. A., Van der Meulen, B. F., Ruijssenaars, W. A. & Timmerman, M. E. Validity and suitability of the Bayley-III Low Motor\/Vision version: A comparative study among young children with and without motor and\/or visual impairments. Res. Dev. Disabil. 34, 3736\u20133745 (2013).","journal-title":"Res. Dev. Disabil."},{"key":"9053_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.siny.2015.06.004","volume":"20","author":"N Beligere","year":"2015","unstructured":"Beligere, N. et al. Retinopathy of prematurity and neurodevelopmental disabilities in premature infants. Semin. Fetal Neonatal Med. 20, 346\u2013353 (2015).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"9053_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","volume":"22","author":"KA Kennedy","year":"2018","unstructured":"Kennedy, K. A., Mintz-Hittner, H. A. & Group, B.-R.C. Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity. J AAPOS 22, 61\u201365 (2018).","journal-title":"J AAPOS"},{"key":"9053_CR18","doi-asserted-by":"publisher","first-page":"e0223972","DOI":"10.1371\/journal.pone.0223972","volume":"14","author":"YS Chang","year":"2019","unstructured":"Chang, Y. S. et al. Involution of retinopathy of prematurity and neurodevelopmental outcomes after intravitreal bevacizumab treatment. PLoS ONE 14, e0223972 (2019).","journal-title":"PLoS ONE"},{"key":"9053_CR19","doi-asserted-by":"publisher","first-page":"e20200056A","DOI":"10.1542\/peds.2020-0056A","volume":"145","author":"SH Rodriguez","year":"2020","unstructured":"Rodriguez, S. H. et al. Neurodevelopmental outcomes of preterm infants with retinopathy of prematurity by treatment. Pediatrics 145, e20200056A (2020).","journal-title":"Pediatrics"},{"key":"9053_CR20","doi-asserted-by":"publisher","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","volume":"137","author":"J Morin","year":"2016","unstructured":"Morin, J. et al. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics 137, e20153218 (2016).","journal-title":"Pediatrics"},{"key":"9053_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner, H. A., Kennedy, K. A., Chuang, A. Z. & Group, B.-R.C. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N. Engl. J. Med. 364, 603\u2013615 (2011).","journal-title":"N. Engl. J. Med."},{"key":"9053_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","volume":"128","author":"CY Tsai","year":"2021","unstructured":"Tsai, C. Y. et al. Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: A meta-analysis. Ophthalmology 128, 877\u2013888 (2021).","journal-title":"Ophthalmology"},{"key":"9053_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pedneo.2014.05.002","volume":"56","author":"BH Su","year":"2015","unstructured":"Su, B. H. et al. Neonatal outcomes of extremely preterm infants from Taiwan: Comparison with Canada, Japan, and the USA. Pediatr. Neonatol. 56, 46\u201352 (2015).","journal-title":"Pediatr. Neonatol."},{"key":"9053_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3345\/cep.2019.00822","volume":"63","author":"JH Lee","year":"2020","unstructured":"Lee, J. H., Youn, Y. & Chang, Y. S. Short- and long-term outcomes of very low birth weight infants in Korea: Korean Neonatal Network update in 2019. Clin. Exp. Pediatr. 63, 284\u2013290 (2020).","journal-title":"Clin. Exp. Pediatr."},{"key":"9053_CR25","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1111\/j.1651-2227.2011.02517.x","volume":"101","author":"JR Lowe","year":"2012","unstructured":"Lowe, J. R., Erickson, S. J., Schrader, R. & Duncan, A. F. Comparison of the Bayley II Mental Developmental Index and the Bayley III Cognitive Scale: Are we measuring the same thing?. Acta Paediatr. 101, e55-58 (2012).","journal-title":"Acta Paediatr."},{"key":"9053_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archpediatrics.2010.20","volume":"164","author":"PJ Anderson","year":"2010","unstructured":"Anderson, P. J. et al. Underestimation of developmental delay by the new Bayley-III Scale. Arch. Pediatr. Adolesc Med. 164, 352\u2013356 (2010).","journal-title":"Arch. Pediatr. Adolesc Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09053-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09053-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09053-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:45:17Z","timestamp":1669337117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09053-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9053"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09053-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"27 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5053"}}